TORONTO--(BUSINESS WIRE)--CardioComm Solutions, Inc. (CardioComm Solutions) (TSX-V: EKG), received confirmation from the Canadian Medical Devices Conformity Assessment System (CMDCAS) that it had cleared an ISO audit performed by DQS Medizinprodukte GmbH. CardioComm Solutions is registered under Health Canada’s Therapeutic Products Programme (TPP) according to ISO 13485:2003 and CMDCAS as well as MDD regulations, for the ‘Manufacturing and Distribution of Health Management Software Systems and Distribution of Health Monitoring Devices.’ The mission of the TPP, and the purpose of the audit, is to ensure that drugs, medical devices, and other therapeutic products available in Canada are safe, effective and of high quality.
